Entire Transcript in Adobe Acrobat Format - National Reference ...

66
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
need to be concerned about -- in some sense the genetic
ones raise some issues because you can have a genetic
fingerprint but the policy has to be broad to cover all the
items.
Now, I mean it may be a worthwhile intellectual
exercise to say let's look at the Guthrie Cards and let's
look at the pathological samples.
What are the kind of different protections you
would like, Alex, or you think might be in place there?
Would you -- and here is where -- would you in the
pathological -- in the case of the pathology samples want
to have full consent because -- on existing pathology
samples because that is what I think would be required?
I would just say that in my reading of the
literature no one has suggested that.
MR. CAPRON: Why isn't that a matter of the
choice of the subject? In other words, looking at the
breast cancer documents and the --
DR. EMANUEL: In existing samples?
MR. CAPRON: No, not existing samples. Excuse
me. Future samples.
DR. EMANUEL: But that is what we were talking
about. In existing samples --
MR. CAPRON: The existing -- you had moved